First, the effect of ENDOU overexpression can be validated in other HNSCC cell lines, and if possible, the impact of ENDOU silencing or mutation on HNSCC cell lines to support the conclusion. This evidence concerns the gene ENDOU and head and neck squamous cell carcinoma.